logo

For the Inventor, By the Inventor

Westborough, MA, United States of America

A K Gunnar Aberg

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal13 out of 322 
 
Sepracor, Inc.
 patents

Years Active: 2001-2007

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7214684 - Methods for the treatment of allergic rhinitis (2007-05-08),
2. 7214683 - Compositions of descarboethoxyloratadine (2007-05-08),
3. 7211582 - Methods for treating urticaria using descarboethoxyloratadine (2007-05-01),
4. 6534508 - Methods and compositions for treating infection using optically pure (S)-lomefloxacin (2003-03-18),
5. 6458809 - Methods for treating disorders using norastemizole in combination with other active ingredients (2002-10-01),
6. 6384054 - Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients (2002-05-07),
7. 6337339 - Methods and compositions for treating infection using optically pure (S)-lomefloxacin (2002-01-08),
8. 6313144 - Compositions of optically pure (−) norcisapride (2001-11-06),
9. 6303632 - Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients (2001-10-16),
10. 6274595 - Compositions for treating infection using optically pure (S)-lomefloxacin (2001-08-14),
11. 6268382 - Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients (2001-07-31),
12. 6187795 - Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients (2001-02-13),
13. 6187794 - Methods for treating allergic disorders and other disorders using norastemizole (2001-02-13),

Title: The Innovative Contributions of A K Gunnar Aberg in Allergy Treatment

Introduction

A K Gunnar Aberg is a prominent inventor based in Westborough, MA, known for his significant contributions to the field of allergy treatments. With a total of 13 patents to his name, Aberg has focused on innovative approaches to improve the efficacy and safety of antihistamines.

Latest Patents

Among Aberg's latest inventions are pivotal patents concerning the compositions of descarboethoxyloratadine (DCL). These methods utilize DCL, a metabolic derivative of loratadine, to treat allergic rhinitis and various other disorders. Notably, these innovative methods aim to avoid the adverse side effects often associated with traditional non-sedating antihistamines, marking a considerable advancement in allergy treatment.

Career Highlights

Aberg has made substantial contributions during his time at Sepracor, Inc., a company renowned for its focus on healthcare and novel therapies. His work has helped shape modern treatments for allergies, reflecting his commitment to improving patient care through inventive pharmaceutical developments.

Collaborations

Throughout his career, A K Gunnar Aberg has collaborated with other esteemed professionals in the field, including colleagues such as Raymond L Woosley and John R McCullough. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patents.

Conclusion

A K Gunnar Aberg's dedication to innovation in allergy treatment underscores his importance as an inventor. His latest patents highlight the potential for safer, more effective treatments for allergic rhinitis. Aberg's work at Sepracor, Inc., along with his collaborations, continues to influence the pharmaceutical landscape and improve the lives of those suffering from allergies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…